- Selma Blair revealed via Instagram that she is undergoing a stem cell treatment called hematopoietic stem cell transplantation (HSCT) to slow down her multiple sclerosis.
- This experimental treatment uses chemotherapy to reset and rebuild a patient’s immune system.
- The therapy includes many of the risks and side effects of traditional chemotherapy, including hair loss.
- In recent phase 2 clinical trials, HSCT showed promise in slowing the progression of relapsing-remitting MS compared to existing disease-modifying drugs.
In a recent Instagram post, actress Selma Blair showed off her newly shaven head and announced she “did HSCT” in an effort to slow down the progression of her multiple sclerosis.
This left many in the MS community wondering about the specifics of this new and relatively unknown treatment for MS.
Hematopoietic stem cell transplantation (HSCT) is a complicated and still experimental therapy that uses mild to stronger forms of chemotherapy to reset a patient’s immune system, erasing the memory of MS.
MS is largely recognized as an autoimmune condition, where the body’s natural defenses become confused and attack healthy tissues in the central nervous system.
HSCT carries many of the side effects associated with traditional chemotherapy, including hair loss, which likely explains Blair’s social media posts.
………………………………………………………………………………..
STAY informed of MS news and information
Click here to opt-in
This Article is Provided by: #MSViewsandNews
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews